Can acceptance and commitment therapy ease chronic pain as well as CBT?

NCT ID NCT07709572

First seen Jul 16, 2026 · Last updated Jul 17, 2026 · Updated 1 time

Summary

This study tests whether acceptance and commitment therapy (ACT) helps adults with chronic non-malignant pain (pain lasting 3+ months not caused by cancer). Sixty participants are randomly assigned to ACT, cognitive behavioral therapy (CBT), or standard medical care alone. Both ACT and CBT involve 10 weekly sessions with a trained therapist. The goal is to see if ACT improves pain acceptance, psychological flexibility, and daily functioning compared to CBT or usual care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Acceptance and Commitment Therapy (ACT) and Cognitive Behavioral Therapy (CBT) — both delivered as 10-session psychological interventions
What this could lead to
If ACT proves as good as or better than CBT, it could offer people with chronic pain another effective psychological option to improve daily functioning and quality of life.
What could go wrong
This is a small, early-stage trial with only 60 participants, so results may not apply to everyone. Both therapies require commitment to 10 weekly sessions, and not everyone may benefit.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CHRONIC NON-MALIGNANT PAIN (CHRONIC MUSCULOSKELETAL PAIN, CHRONIC WIDESPREAD PAIN) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • DHQ Hospital, Gujranwala (Orthopedic Department)

    Guiranwala, Punjab Province, 52250, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.